Board of Directors
Dr. Ray Muzyka
CEO, ThresholdImpact
Angel investor in technology, health/biotech/medical innovations, founding partner of CDL, social enterprise at ThresholdImpact. Co-founder/former CEO BioWare, past emergency/family med MD, Ivey MBA, Rotman/SFU ICD.D.
Originally trained as a MD, Dr. Ray Muzyka co-founded BioWare (www.bioware.com) in the early 1990s. After two years of full-time medical practice, rural emergency room/family medicine transitioned over a decade to part-time as he focused on his role as BioWare’s CEO for the next two decades, the last five years as SVP/Group GM of the BioWare division of Electronic Arts. Ray retired from video games in 2012, with his third career chapter at ThresholdImpact (www.thresholdimpact.com) focused on sustainable, profitable impact investing – mentoring and angel investing in deep-tech social enterprise, health and medical innovations.
ThresholdImpact (https://thresholdimpact.com/about/) as of 2026 has made investments in ~100 portfolio companies, participating in over 200+ financing rounds, focusing primarily on angel investments in pre-Seed, Seed, and Series A health and medtech teams, for example in diagnostic and therapeutic medical devices, healthtech software, drug discovery AI, pharmaceuticals, biotechnology, wellness, rehabilitation, robotics, and a range of other deep technology with social impact.
He obtained his BMedSci at the University of Alberta in 1990, his MD at UAlberta in 1992 and CCFP in 1994, his MBA from Ivey’s School of Business (University of Western Ontario) in 2001, and his ICD.D(UToronto-Rotman’s Director Education Program at Simon Fraser University) in 2026.
He was inducted into the Order of Canada in 2018, the Academy of Interactive Arts and Sciences’; Hall of Fame in 2011, Alberta’s Business Hall of Fame in 2018, received the Venture Capital Association of Alberta’s Rod Charko Service Award in 2019, the International Game Developers Association’s 2013 Lifetime Achievement Award, U of A’s 2015 Alumni Innovation Award, MacEwan University’s 2017 Allard Chair in Business, twice named Mentor of the Year at the Creative Destruction Lab (2018 and 2025), and named a Fellow of the Royal Canadian Geographic Society in 2021, among other awards.
Marie-Claude Jacques
Chief Commercial Officer, Catheter Precision
Marie-Claude is currently Chief Commercial Officer at Catheter Precision, a US based medical device company focused on novel Electrophysiology products that help physicians, hospitals and patients in the treatment of cardiac arrhythmias.
Marie-Claude’s current role follows a very successful 15 years in sales leadership at Baylis Medical where she was responsible for building and scaling the US business. The strategic plans that Marie-Claude put in place at Baylis Medical allowed the company to have high double-digit sales growth for several years in a row. This, combined with her work in market development, were key to becoming the standard-of-care in left heart access in the US. The company’s success led to the acquisition by Boston Scientific for USD $1.75 Billion in 2022.
Marie-Claude is currently a mentor at The Canadian Entrepreneurs in New England (CENE), where influential entrepreneurs leverage their experience to mentor and grow a new generation of successful Canadian-led companies, and at the Canadian Trade Accelerator in Boston/Cambridge, a program funded by Global Affairs Canada of which Arbutus Medical is an alumnus. She is a member of Chief, a private network for senior executive women to strengthen their leadership and influence, and help others do the same. Jacques is also a member of the Cardiology Inclusion Council at Boston Scientific Corporation.
Paul Geyer
CEO, Nimbus Synergies
Paul is a successful medtech entrepreneur, angel investor, and experienced board member. In 1991, he founded Mitroflow International Inc., a tissue heart valve company.
Paul grew the company from nine employees to more than 125, selling it to Sulzer Medica in 1999 for more than $50M. In 2001, Paul started Medical Ventures (now Neovasc), a specialty vascular device company. As CEO until 2008, Paul raised over $40M in equity financing and grew the company’s product portfolio through internal development and the acquisition of three companies. Paul is currently Executive Chair of LightIntegra Technology Inc., a spinoff from Canadian Blood Services that has developed the ThromboLUX technology, used to determine platelet quality for blood transfusions.
Robert Ritlop
Venture Capital and Growth Equity Investor, Credit Mutuel Equity
Robert is a founder, investor, and engineer with 15 years spanning healthcare, technology, and aerospace. Currently deploying venture capital and growth equity for Canadian innovators at Crédit Mutuel Equity.
Robert brings 15 years of experience across healthcare and technology as a founder, investor, board director, and engineer. At Crédit Mutuel Equity, he focuses on venture capital and growth equity for Canadian innovators, building on a career that includes serving as the inaugural Director of MEDTEQ+’s $14M seed healthcare fund and co-founding a medical device company focused on concussion diagnostics. His career began in aerospace, where he worked as an aerodynamicist and developed flight software for military helicopter simulators. Robert holds bachelor’s and master’s degrees in mechanical engineering from McGill University and an MBA from NYU Stern.
Lawrence Buchan
CEO and Co-founder, Arbutus Medical Inc.
Lawrence Buchan co-founded Arbutus Medical in 2014 alongside research colleagues from the University of British Columbia, and was appointed CEO in 2018.
Lawrence has raised over $5M in capital for Arbutus Medical, has been a co-inventor on 2 patents, with 5 peer reviewed publications in the field of orthopaedics. He was named to the BC Business 30 Under 30 in 2020, and Top 35 BC Healthcare CEOs by BestStartup.ca in 2022.
Lawrence obtained his undergraduate degree (honours) in Mechanical Engineering from the University of Toronto and Masters (honours) in Biomedical Engineering from the University of British Columbia MASc.
Management
Michael Cancilla
Sr. Director of Product, Co-Founder
Geoff Borgmann
Sr. Director of Sales
Livleen Veslemes
Chief Financial and Operating Officer
Jeff Kennelly
Director of Manufacturing Operations
Tricia Gilliss
Human Resources Lead
Medical Advisory Board
Dr. Peter O'Brien
Founding Medical Advisor
Orthopaedic Surgeon
Associate Professor Emeritus & Associate Head, Academic
Department of Orthopaedics (Orthopaedic Trauma)
University of British Columbia
Dr. Scott Nelson
Founding Medical Advisor
Orthopedic Surgeon
Chief of Surgery, Hôpital Adventiste, Port au Prince, Haiti
Associate Professor Orthopedic Surgery, Loma Linda University
Dr. Jeffrey Potter
Founding Medical Advisor
Orthopaedic Surgeon
Clinical Assistant Professor
Department of Orthopaedics (Orthopaedic Trauma)
University of British Columbia
Dr. Greg Pereira
Co-Lead Consultant, Skeletal Traction Product Design Group
Duke Orthopedic Resident PGY5, University of Pennsylvania (MD), Co-Founder MSK Curbsider,
John Kodosky - DHSc, MPAS, PA-C
Co-Lead Consultant, Skeletal Traction Product Design Group
Orthopedic Trauma Physician Assistant at UT Health San Antonio/ Trauma Clinic Medical Director/ Clinical Instructor UT Health San Antonio PA Program/ Medical Science Liaison Arbutus Medical
Investors and Funding Partners
